11:02 AM EDT, 04/02/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts fell Tuesday, dropping 0.79% to 1,362.68 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Cellectis ( CLLS ) , which rose 5.2% and 3.1% respectively. They were followed by biotech firm Biophytis ( BPTS ) and oil and gas company Eni (E), which increased 2.9% and 1.6%.

The decliners from continental Europe were led by hotel booking site trivago (TRVG) and internet browser company Opera (OPRA), which fell 7.1% and 2.7% respectively. They were followed by biopharmaceutical companies Genfit ( GNFT ) and Grifols ( GRFS ) , which dropped 2.5% and 2.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Autolus Therapeutics ( AUTL ) and Akari Therapeutics ( AKTX ) , which were up 2.7% each. They were followed by financial services company Barclays ( JJCTF ) and biopharmaceutical company NuCana ( NCNA ) , which increased 1.4% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Adaptimmune Therapeutics ( ADAP ) , which lost 11% and 4.4% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Amarin ( AMRN ) , which dropped 4% and 2.8% respectively.